- 全部删除
您的购物车当前为空
hPL-IN-2 是一种具有有效性、可逆性、和非竞争性胰脂肪酶 (Pancreatic lipase) 抑制剂 (IC50: 1.63 μM),可用于研究肥胖相关疾病。


为众多的药物研发团队赋能,
让新药发现更简单!
hPL-IN-2 是一种具有有效性、可逆性、和非竞争性胰脂肪酶 (Pancreatic lipase) 抑制剂 (IC50: 1.63 μM),可用于研究肥胖相关疾病。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 191 | In stock | |
| 5 mg | ¥ 453 | In stock | |
| 10 mg | ¥ 749 | In stock | |
| 25 mg | ¥ 1,230 | In stock | |
| 50 mg | ¥ 1,830 | In stock | |
| 100 mg | ¥ 2,590 | In stock | |
| 200 mg | ¥ 3,450 | In stock |
| 产品描述 | hPL-IN-2 is a potent, reversible and non-competitive inhibitor of Pancreatic lipase (IC50: 1.63 μM) that can be used to investigate obesity-related diseases. |
| 靶点活性 | Pancreatic lipase:1.63 μM, PL (human):1.7 μM |
| 分子量 | 443.11 |
| 分子式 | C19H11Cl4NO3 |
| CAS No. | 24900-61-6 |
| Smiles | O=C(NC1=CC=C(OC2=CC=C(Cl)C=C2)C(Cl)=C1)C=3C=C(Cl)C=C(Cl)C3O |
| 密度 | no data available |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 55 mg/mL (124.12 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容